Cleerly LABS vs Zio ECG Utilization Software (ZEUS) System
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if you require a detailed, AI-powered analysis of coronary CT angiography (CCTA) to precisely quantify and characterize atherosclerosis and stenosis. This tool is ideal for assessing a patient's personalized risk of heart attack, monitoring disease progression, and guiding treatment strategies based on comprehensive plaque assessment and 3D visualization of coronary arteries.
View Cleerly LABS →Choose Zio ECG Utilization Software (ZEUS) System if…
Choose the Zio ECG Utilization Software (ZEUS) System if you need to detect and classify cardiac arrhythmias through continuous, long-term ECG monitoring using wearable devices. This platform is best suited for diagnosing and managing patients experiencing symptoms of irregular heartbeats, providing AI-powered analysis of up to 14 days of ECG data for comprehensive end-of-wear reports.
View Zio ECG Utilization Software (ZEUS) System →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | Zio ECG Utilization Software (ZEUS) System |
|---|---|---|
| Pricing | Varies | Unknown |
| Deployment | Cloud, On-premise | Cloud-based. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Zio ECG Utilization Software (ZEUS) SystemBoth tools offer web-based platforms and EHR integration for healthcare professionals. However, the Zio ECG Utilization Software (ZEUS) System explicitly includes a mobile application for healthcare professionals, which provides greater flexibility and on-the-go access, enhancing overall usability.
Clinical Value
Cleerly LABSCleerly LABS, particularly with its ISCHEMIA module, has demonstrated strong clinical validation in multiple trials (CREDENCE, PACIFIC, CLARIFY 2) against invasive FFR, showing high diagnostic accuracy and prognostic utility for major adverse cardiovascular events (MACE). While ZEUS also has robust validation for arrhythmia detection with high diagnostic yield, Cleerly's focus on proactive, personalized heart disease management through comprehensive plaque characterization and ischemia detection offers a potentially more impactful and preventative approach to cardiac care.
Pricing & Value
Cleerly LABSCleerly LABS provides transparent pricing, detailing a per-analysis cost and acknowledging potential out-of-pocket expenses for patients. In contrast, the Zio ECG Utilization Software (ZEUS) System's pricing is not publicly available, making it difficult for potential users to assess its value without direct inquiry.
Enterprise Readiness
TieBoth Cleerly LABS and the Zio ECG Utilization Software (ZEUS) System demonstrate strong enterprise readiness. Both are cloud-based, FDA-cleared, HIPAA compliant, and offer robust EHR integration capabilities, including explicit BAA for Cleerly and implied BAA for ZEUS.
Innovation
Cleerly LABSCleerly LABS offers a highly innovative approach by providing comprehensive AI-powered CCTA analysis to detect, quantify, and characterize atherosclerosis and stenosis, aiming to establish a 'new standard of care' for heart attack prevention. While ZEUS utilizes advanced AI for continuous ECG analysis from wearables, Cleerly's focus on detailed plaque characterization and disease progression tracking represents a more disruptive innovation in the diagnostic pathway for coronary artery disease.
Support & Docs
Zio ECG Utilization Software (ZEUS) SystemiRhythm's Zio ECG Utilization Software (ZEUS) System offers more comprehensive support, including a 24/7 clinical services line and dedicated patient advocates for billing inquiries. Cleerly LABS provides client support during business hours and offers various resources, but lacks the round-the-clock clinical availability of ZEUS.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | Zio ECG Utilization Software (ZEUS) System |
|---|---|---|
| Name | Cleerly LABS | Zio ECG Utilization Software (ZEUS) System |
| Company | Cleerly | iRhythm Technologies |
| Description | AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. | AI-powered, cloud-based platform that analyzes continuous ECG data from wearable Zio monitors to aid physicians in the diagnosis and management of cardiac arrhythmias. |
| Primary Data Input | Coronary CT angiography (CCTA) images | Continuous ECG data from wearable Zio monitors |
| Key Functionality | Comprehensive coronary plaque assessment, stenosis detection and quantification, ischemia detection, personalized heart disease risk assessment. | AI algorithm for arrhythmia detection and classification, continuous ECG data analysis, comprehensive end-of-wear reports. |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and Zio ECG Utilization Software (ZEUS) System.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or Zio ECG Utilization Software (ZEUS) System
Backers
Who funded each tool's parent company.